Sansure Biotech Inc. (SHA:688289)

Sansure Biotech Revenue

Sansure Biotech had revenue of 396.97M CNY in the quarter ending June 30, 2026, with 0.98% growth. This brings the company's total for the last twelve months to 1.61B, down -0.15% year-over-year. In the year 2025, Sansure Biotech had annual revenue of 1.64B with 12.58% growth. That makes Sansure Biotech the 16,099th largest company in the world by revenue and 2,907th in China.

• Revenue (ttm): 1.61B
• Revenue Growth: -0.15%
• P/S Ratio: 5.48
• Revenue / Employee: 778.70K
• Employees: 2,064
• Market Cap: 8.81B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 1.53B 94.9%
• Overseas 83.08M 5.1%

Fiscal year ended Dec 31, 2025 See the full Sansure Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.64B	183.47M	12.58%
Dec 31, 2024	1.46B	450.94M	44.78%
Dec 31, 2023	1.01B	-5.44B	-84.39%
Dec 31, 2022	6.45B	1.94B	42.88%
Dec 31, 2021	4.51B	-248.42M	-5.22%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error